Basics Tevogen Bio Holdings Inc. Common Stock IPO Date: February 15, 2024 Sector: Healthcare Industry: Biotech Market Cap: $132.56M Activated in VL: True Average Daily Range Avg Daily Range: $0.11 | 5.80% Avg Daily Range (30 D): $0.03 | 3.72% Avg Daily Range (90 D): $0.03 | 2.81% Institutional Daily Volume Avg Daily Volume: 2.78M Avg Daily Volume (30 D): .41M Avg Daily Volume (90 D): .59M Trade Size Avg Trade Size (Sh.): 311 Avg Trade Size (Sh.) (30 D): 317 Avg Trade Size (Sh.) (90 D): 317 Institutional Trades Total Inst.Trades: 4 Avg Inst. Trade: $.83M Avg Inst. Trade (30 D): $.98M Avg Inst. Trade (90 D): $.98M Avg Inst. Trade Volume: .68M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $.86M Avg Closing Trade (30 D): $.98M Avg Closing Trade (90 D): $.98M Avg Closing Volume: 913.51K     News Oct 15, 2025 @ 7:50 PM Tevogen Updates on TVGN 489 Following Growing Long... Source: Dr. Ryan Saadi Sep 19, 2025 @ 7:40 PM Tevogen Commends HHS for Addressing Long COVID, Em... Source: Tevogen Bio Holdings Inc. Aug 18, 2025 @ 9:50 PM Tevogen CEO Donates Personal Shares to Support Loc... Source: Dr. Ryan Saadi Aug 12, 2025 @ 3:09 PM Healthcare AI Market Explodes 38.5% Annually as Di... Source: Prnewswire Aug 11, 2025 @ 3:58 PM Tevogen Bio Oncology Reports Top-Line Revenue Fore... Source: Sadiq Khan (Chief Commercial Officer) Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.03 $-.07 $-.06 Diluted EPS $-.03 $-.07 $-.06 Revenue $ -.04M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -5.5M $ -10.37M $ -9.44M Operating Income / Loss $ -5.44M $ -10.36M $ -9.36M Cost of Revenue $ $ $ Net Cash Flow $ M $ M $ M PE Ratio